KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Short term Debt (2016 - 2025)

AbbVie (ABBV) has disclosed Short term Debt for 14 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 63.27% to $2.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 63.27% year-over-year, with the annual reading at $2.5 billion for FY2025, 63.27% down from the prior year.
  • Short term Debt for Q4 2025 was $2.5 billion at AbbVie, up from $2.0 billion in the prior quarter.
  • The five-year high for Short term Debt was $12.6 billion in Q2 2024, with the low at $1.0 million in Q1 2023.
  • Average Short term Debt over 5 years is $5.1 billion, with a median of $4.1 billion recorded in 2022.
  • The sharpest move saw Short term Debt crashed 99.99% in 2023, then skyrocketed 1019200.0% in 2024.
  • Over 5 years, Short term Debt stood at $14.0 million in 2021, then surged by 29435.71% to $4.1 billion in 2022, then soared by 73.91% to $7.2 billion in 2023, then dropped by 5.38% to $6.8 billion in 2024, then crashed by 63.27% to $2.5 billion in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $2.5 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.